- Home
- LX vs BLFS Comparison
LX vs BLFS Comparison
Compare LX & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LX
- BLFS
- Stock Information
- Founded
- LX 2013
- BLFS 1987
- Country
- LX China
- BLFS United States
- Employees
- LX N/A
- BLFS N/A
- Industry
- LX Finance: Consumer Services
- BLFS Medical/Dental Instruments
- Sector
- LX Finance
- BLFS Health Care
- Exchange
- LX Nasdaq
- BLFS Nasdaq
- Market Cap
- LX 1.1B
- BLFS 1.2B
- IPO Year
- LX 2017
- BLFS 1989
- Fundamental
- Price
- LX $5.70
- BLFS $25.77
- Analyst Decision
- LX
- BLFS Strong Buy
- Analyst Count
- LX 0
- BLFS 7
- Target Price
- LX N/A
- BLFS $30.86
- AVG Volume (30 Days)
- LX 3.2M
- BLFS 468.4K
- Earning Date
- LX 08-07-2025
- BLFS 11-11-2025
- Dividend Yield
- LX 6.62%
- BLFS N/A
- EPS Growth
- LX 86.38
- BLFS N/A
- EPS
- LX 1.28
- BLFS N/A
- Revenue
- LX $1,956,013,429.00
- BLFS $93,468,000.00
- Revenue This Year
- LX $5.90
- BLFS $26.07
- Revenue Next Year
- LX $21.30
- BLFS $16.86
- P/E Ratio
- LX $4.52
- BLFS N/A
- Revenue Growth
- LX 0.80
- BLFS 68.16
- 52 Week Low
- LX $1.63
- BLFS $19.10
- 52 Week High
- LX $11.64
- BLFS $29.55
- Technical
- Relative Strength Index (RSI)
- LX 34.67
- BLFS 56.89
- Support Level
- LX $5.83
- BLFS $25.85
- Resistance Level
- LX $6.23
- BLFS $27.52
- Average True Range (ATR)
- LX 0.22
- BLFS 0.76
- MACD
- LX -0.04
- BLFS -0.03
- Stochastic Oscillator
- LX 2.09
- BLFS 42.81
About LX LexinFintech Holdings Ltd.
LexinFintech Holdings Ltd is an online consumer finance platform and a technology-driven service provider in China. The group is engaged in online direct sales services and online consumer finance services for its customers in the PRC. Geographically, it derives revenue from China.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.